Aino Health ABOSTO:AINO 26 EBITDA Margin % is -23.68% as of Mar. 2026. GuruFocus rates OSTO:AINO with a GF Score™ of 26/100 and a GF Value™ of kr0.13 (Fairly Valued). The stock has 4 warning signs investors should review. Among 665 Healthcare Providers & Services companies, Aino Health AB ranks worse than 83.61% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Aino Health AB's EBITDA for the
three
months ended in Mar. 2026 was kr-1.31 Mil. Aino Health AB's Revenue for the
three
months ended in Mar. 2026 was kr5.53 Mil. Therefore, Aino Health AB's EBITDA margin for the quarter that ended in Mar. 2026 was -23.68%.
Aino Health AB (OSTO:AINO) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Aino Health AB EBITDA Margin % Related Terms
Aino Health AB EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Aino Health AB's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OSTO:AINO vs VEEV, BTSG, TEM: EBITDA Margin % Comparison
For the Health Information Services subindustry, Aino Health AB's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Aino Health AB EBITDA Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Aino Health AB's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Aino Health AB's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Aino Health AB (OSTO:AINO) has a EBITDA Margin % of -23.68% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Aino Health AB and its competitors. According to the industry distribution chart, Aino Health AB ranks #556 out of 665 companies in the Healthcare Providers & Services industry, placing it in the top 83.6%.
Is Aino Health AB's EBITDA Margin % too high?
Aino Health AB's current EBITDA Margin % is -23.68%. Based on the distribution chart, Aino Health AB ranks #556 out of 665 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Aino Health AB has a GF Score™ of 26/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Aino Health AB's EBITDA Margin % compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Aino Health AB ranks #556 out of 665 companies for EBITDA Margin %. This places Aino Health AB in the lower half of its industry. The industry median EBITDA Margin % is 10.24. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Providers & Services company?
The median EBITDA Margin % among Healthcare Providers & Services companies is 10.24, based on 665 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Aino Health AB and its competitors. For the Healthcare Providers & Services industry, the median EBITDA Margin % is 10.24 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Aino Health AB's current EBITDA Margin % is -23.68%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aino Health AB stock overvalued right now?
Based on GuruFocus' analysis, Aino Health AB (OSTO:AINO) is currently considered Fairly Valued. The stock's GF Value™ is kr0.13, compared to a current price of kr0.13 — trading 1.5% below its estimated fair value. The current EBITDA Margin % is -23.68%. Aino Health AB's overall GF Score™ is 26/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Aino Health AB (OSTO:AINO), the current EBITDA Margin % is -23.68% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Aino Health AB (OSTO:AINO) Overvalued in 2026?
Based on GuruFocus' analysis, Aino Health AB stock appears to be undervalued.
The current stock price of kr0.13 is trading 1.5% below its estimated GF Value™ of kr0.13.
GuruFocus considers Aino Health AB to be Fairly Valued.
Key valuation signals for OSTO:AINO:
EBITDA Margin %: -23.68%
GF Value™: kr0.13 vs. price of kr0.13 (1.5% below fair value)
No single metric tells the full story. See the OSTO:AINO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Aino Health AB provides corporate health management solutions. The company has developed a complete system of IT-based services with a focus on improving corporate health and reducing sickness absence levels in private and public organizations. Its solution consists of HealthManager, HealthDesk, and Consulting services. Company SaaS platform combines advance data analytics, research-based insights, and AI to empower leaders to unlock the full potential of their teams and to foster a healthier, more sustainable work environment.
26GF Score
Get the complete analysis for OSTO:AINO
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSTO:AINO has been successfully added to your 
